• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493941828350
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/08/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that shaft break occurred.The patient underwent a percutaneous coronary intervention.The 75% stenosed complex target lesion was located in the moderately tortuous and severely calcified circumflex artery.A 3.50 x 28mm synergy xd stent was advanced for treatment and was successfully implanted.However, when attempting to remove the stent delivery system, the shaft fractured.It had to be removed inside the guide catheter.Everything was successfully removed from the body without complications.No patient complications were reported and the patient status was stable.
 
Additional Manufacturer Narrative
Device evaluated by mfr: the synergy xd mr us 3.50 x 28mm stent delivery system (sds) was returned for analysis.Visual and tactile inspection revealed a shaft break was noted at the site of the guidewire port.A visual and tactile examination of the outer and inner lumen and mid-shaft section found no issues.Microscopic analysis showed no stent was attached to the device as it was successfully implanted.Balloon profile: balloon cones were reviewed and was subjected to positive pressure.Bumper tip showed no signs of distal tip damage.
 
Event or Problem Description
It was reported that shaft break occurred.The patient underwent a percutaneous coronary intervention.The 75% stenosed complex target lesion was located in the moderately tortuous and severely calcified circumflex artery.A 3.50 x 28mm synergy xd stent was advanced for treatment and was successfully implanted.However, when attempting to remove the stent delivery system, the shaft fractured.It had to be removed inside the guide catheter.Everything was successfully removed from the body without complications.No patient complications were reported and the patient status was stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17174059
Report Number2124215-2023-32160
Device Sequence Number20698466
Product Code NIQ
UDI-Device Identifier08714729981077
UDI-Public08714729981077
Combination Product (Y/N)Y
Initial Reporter StateOH
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/03/2024
Device Model NumberH7493941828350
Device Lot Number0029737067
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 06/09/2023
Supplement Date Received by Manufacturer08/15/2023
Initial Report FDA Received Date06/21/2023
Supplement Report FDA Received Date08/25/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/04/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-